Association between polycystic ovary syndrome and the risk of pregnancy complications A PRISMA-compliant systematic review and meta-analysis

Medicine (United States)

Volumn 95, Issue 51, 2016, Pages e4863-

  Yu, Hai Feng ^a   Chen, Hong Su ^a   Rao, Da Pang ^a   Gong, Jian ^b  

^a Department of Urosurgery ^*  (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Meta Analysis; polycystic ovary syndrome; pregnancy complications; risk; systematic review

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADVERSE OUTCOME; CESAREAN SECTION; CHOLESTEROL BLOOD LEVEL; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; HUMAN; HYDRAMNIOS; HYPOGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; LARGE FOR GESTATIONAL AGE; MACROSOMIA; MATERNAL HYPERTENSION; OBSERVATIONAL STUDY; OLIGOHYDRAMNIOS; OVARY POLYCYSTIC DISEASE; PERINATAL DEATH; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; COMPLICATION; DIABETES, GESTATIONAL; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; META ANALYSIS; OBSTETRIC LABOR, PREMATURE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTOR;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; OBSTETRIC LABOR, PREMATURE; POLYCYSTIC OVARY SYNDROME; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 85007359570     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004863     Document Type: Review

References (60)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-61.
2. Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRFJASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28-38.
3. Ansari RM. Potential use of durian fruit (Durio zibenthinus Linn) as an adjunct to treat infertility in polycystic ovarian syndrome. J Integr Med 2016;14:22-8.
4. Katulski K, Czyzyk A, Podfigurna-Stopa A, et al. Pregnancy complications in polycystic ovary syndrome patients. Gynecol Endocrinol 2015;31:87-91.
5. Falbo A, Rocca M, Russo T, et al. Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes. JOvarian Res 2010;3:23.
6. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Am J Obstet Gynecol 2011;204:558e1-6.
7. Qin JZ, Pang LH, Li MJ, et al. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2013;11:56.
8. Toulis KA, Goulis DG, Kolibianakis EM, et al. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril 2009;92:667-77.
9. Sawada M, Masuyama H, Hayata K, et al. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome. Endocr J 2015;62:1017-23.
10. Sir-Petermann T, Echiburu B, Maliqueo MM, et al. Serum adiponectin and lipid concentrations in pregnant women with polycystic ovary syndrome. Hum Reprod 2007;22:1830-6.
11. Hu S, Leonard A, Seifalian A, et al. Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Hum Reprod 2007;22:1532-9.
12. Yan X, Shi Y, Sheng Y, et al. Pregnancy outcomes of patients with polycystic ovary syndrome undergoing in vitro fertilization and embryo transfer. Chin J Obstet Gynecol 2011;46:923-7.
13. Haakova L, Cibula D, Rezabek K, et al. Pregnancy outcome in women with PCOS and in controls matched by age and weight. Hum Reprod 2003;18:1438-41.
14. Lesser KB, Garcia FA. Association between polycystic ovary syndrome and glucose intolerance during pregnancy. J Matern Fetal Med 1997;6:303-7.
15. Laven JS, Imani B, Eijkemans MJ, et al. New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 2002;57:755-67.
16. Palomba S, Falbo A, Russo T, et al. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril 2010;94:1805-11.
17. Vollenhoven B, Clark S, Kovacs G, et al. Prevalence of gestational diabetes rnellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins. Aust N Z J Obstet Gynaecol 2000;40:54-8.
18. Wortsman J, de Angeles S, Futterweit W, et al. Gestational diabetes and neonatal macrosomia in the polycystic ovary syndrome. J Reprod Med 1991;36:659-61.
19. Cardenas M, Coulson CC, Legro RS. Infertile PCOS women do not have an increased risk for gestational diabetes or macrosomia [abstract]. Hum Reprod Update 2006;12:673-83.
20. Aktun HL, Yorgunlar B, Acet M, et al. The effects of polycystic ovary syndrome on gestational diabetes mellitus. Gynecol Endocrinol 2015;19:1-4.
21. Li G, Fan L, Zhang L, et al. Clinical characteristics and perinatal outcomes of non-overweight/obese pregnant women with polycystic ovary syndrome. Natl Med J China 2011;91:2753-6.
22. Koster MP, de Wilde MA, Veltman-Verhulst SM, et al. Placental characteristics in women with polycystic ovary syndrome. Hum Reprod 2015;30:2829-37.
23. Fridström M, Nisell H, Sjöblom P, et al. Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia? Hypertens Pregnancy 1999;18:73-80.
24. Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999;94:194-7.
25. Al-Ojaimi EH. Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome. Saudi Med J 2006;27:519-25.
26. Palomba S, Falbo A, Chiossi G, et al. Lipid profile in nonobese pregnant women with polycystic ovary syndrome: a prospective controlled clinical study. Steroids 2014;88:36-43.
27. Reyes-Munõz E, Castellanos-Barroso G, Ramírez-Eugenio BY, et al. The risk of gestational diabetes mellitus among Mexican women with a history of infertility and polycystic ovary syndrome. Fertil Steril 2012;97:1467-71.
28. Altieri P, Gambineri A, Prontera O, et al. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010;149:31-6.
29. de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998;76:91-5.
30. Urman B, Sarac E, Dogan L, et al. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 1997;42:501-5.
31. Wang Y, Zhao X, Zhao H, et al. Risks for gestational diabetes mellitus and pregnancy-induced hypertension are increased in polycystic ovary syndrome. Biomed Res Int 2013;2013:182582.
32. Palomba S, Falbo A, Russo T, et al. The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome. Diabetes Care 2012;35:861-7.
33. Kollmann M, Klaritsch P, Martins WP, et al. Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions. Hum Reprod 2015;30:2396-403.
34. Foroozanfard F, Moosavi SG, Mansouri F, et al. Obstetric and neonatal outcome in PCOS with gestational diabetes mellitus. J Family Reprod Health 2014;8:7-12.
35. Pan M-L, Chen L-R, Tsao H-M, et al. Relationship between polycystic ovarian syndrome and subsequent gestational diabetes mellitus: a nationwide population-based study. PLoS One 2015;10:e0140544.
36. Aziz Z, Ash A. Pregnancy outcomes in women with polycystic ovary syndrome; a 10-year retrospective study in an inner city London teaching hospital. BJOG: Int J Obstet Gynaecol 2013;EP1. 293 [abstract].
37. West S, Vaäräsmäki M, Piltonen T, et al. Polycystic ovary syndrome and its symptoms increase the risk of pregnancy complications: populationbased cohort study. Abstracts of the 30th Annual Meeting of ESHRE, Munich, Germany, 29 June-2 July, 2014. O-176. [absrtact].
38. Sir-Petermann T, Hitchsfeld C, Maliqueo M, et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005;20:2122-6.
39. Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1357-63.
40. Turhan NO, Seçkin NC, Aybar F, et al. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet 2003;81:163-8.
41. Diamant YZ, Rimon E, Evron S. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 1982;14:199-204.
42. Bjercke S, Dale PO, Tanbo T, et al. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 2002;54:94-8.
43. Li G, Fan L, Zhang L, et al. Metabolic parameters and perinatal outcomes of gestational diabetesmellitus in women with polycystic ovary syndrome. J Perinat Med 2010;38:141-6.
44. Maliqueo M, Echiburu B, Crisosto N, et al. Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome. Fertil Steril 2009;92:277-82.
45. Mikola M, Hiilesmaa V, Halttunen M, et al. Obstetric outcome in womenwith polycystic ovarian syndrome. Hum Reprod 2001;16:226-9.
46. Weerakiet S, Srisombut C, Rojanasakul A, et al. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2004;19:134-40.
47. Kashyap S, Claman P. Polycystic ovary disease and the risk of pregnancyinduced hypertension. J Reprod Med 2000;45:991-4.
48. Foroozanfard F, Moosavi SGA, Ghattan N, et al. Obstetric and neonatal outcome in PCOS with gestational diabetes mellitus. Iran J Reprod Med 2013;11(Suppl 2):4-5.
49. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
50. Wells G, Shea B, O'Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute 2009; Available in March 2016: http://www. ohri. ca/programs/clinical-epidemiology/oxford. htm.
51. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
52. Ades AE, Lu G, Higgins JP. The interpretation of random-effects metaanalysis in decision models. Med Decis Making 2005;25:646-54.
53. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
54. Deeks JJ, Higgins JPT, Altman DG. Higgins J, Green S. Analyzing data and undertaking meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions 5. 0. 1. Oxford, UK:The Cochrane Collaboration; 2008;Chap 9.
55. Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull 1999; 47:15-7.
56. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
57. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
58. Duvall S, Tweedie R. A nonparametric "trim and fill" method for assessing publication bias in meta-analysis. J Am Stat Assoc 2000;95:89-98.
59. de Wilde MA, Veltman-Verhulst SM, Goverde AJ, et al. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome. Hum Reprod 2014;29:1327-36.
60. Norman RJ, Masters L, Milner CR, et al. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995-8.